Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia
Journal of Small Animal Practice · 2024
DOI: 10.1111/jsap.13700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Small Animal Practice, 2024. Verfasst von E Stikeman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA. Hauptthemen laut MEDLINE: Dog Diseases, Immunoglobulins, Intravenous, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Objectives To evaluate the safety and efficacy of human intravenous immunoglobulin in dogs with newly diagnosed malignancy and presumed secondary immune‐mediated thrombocytopenia. Materials and Methods Twelve client‐owned dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia were prospectively enrolled to receive a single infusion of human intravenous immunoglobulin at a dose of 0.5 to 1 mg/kg intravenous over 8 hours. A complete treatment response was defined as a platelet estimation of ≥40,000 platelets/μL within 24 hours and a partial response within 48 hours from the completion of human intravenous immunoglobulin infusion. No treatment response was defined as a platelet estimation remaining
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA.
Zitieren
APA
Stikeman, E., & Bianco, D. (2024). Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13700
Vancouver
Stikeman E, Bianco D. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13700
BibTeX
@article{Stikeman2024,
author = {Stikeman, E and Bianco, D},
title = {Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia},
journal = {Journal of Small Animal Practice},
year = {2024},
doi = {10.1111/jsap.13700}
}
EUVIMED